2023. Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time as a Clinical Variable. Translational Medicine & Therapeutics Journal. 2, 1 (Jan. 2023), 1–9. DOI:https://doi.org/10.5281/zenodo.22649019.